INHSU 2026 invites abstract submissions showcasing original research that enhances the health and quality of life of people who use drugs. We welcome contributions across a broad range of topics, including health issues beyond hepatitis C.
The deadline for abstract submissions is 11:59 PM (CET), Sunday 1 March 2026.
Submission Options
- Abstract Submissions Portal – for oral presentations and posters
- Discussion Spaces & Workshops Portal – for interactive sessions
- Curated Sessions – for thematic sessions and panels focused on a specific topic
We particularly encourage abstracts addressing:
- Prevention, testing, and treatment of viral hepatitis, HIV, and other drug-related harms
- Overdose prevention
- Harm reduction for stimulant use
- Public health policy, service delivery, and innovative healthcare interventions for people who use drugs
- Research, models of care, and examples of effective program delivery for marginalised populations, including but not limited to women who use drugs, people experiencing homelessness, migrants, and Indigenous peoples
Submissions focusing on specific sub-populations (e.g., by gender or age) or on low- and middle-income country settings are strongly encouraged to support equitable access to care globally.
For detailed submission guidelines and access to the submission portals, please visit:
https://inhsu.org/inhsu-2026/
About INHSU 2026
INHSU conferences consistently showcase groundbreaking global research in these fields prior to publication in leading journals, including The Lancet Global Health, The Lancet Gastroenterology and Hepatology, International Journal of Drug Policy, Journal of Viral Hepatitis, and many others.
INHSU2026_Save the Date_PDF.pdf
INHSU2026_Save the Date_PPT.pptx
